Our findings revealed that the regain of ANKDD1A expression resulted in reduced transactivation function and stability of HIF1α, which suppressed GBM cells from adapting to hypoxia, inhibited cell autophagy and induced apoptosis in hypoxic microenvironment. The gene discussed is ANKDD1A; the disease is glioblastoma.